COMMUNIQUÉS West-GlobeNewswire
-
ReFocus Eye Health Expands Presence Through Strategic Affiliation with Seven Partner Practices and Four Ambulatory Surgery Centers
17/03/2026 -
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
17/03/2026 -
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions
17/03/2026 -
Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates
17/03/2026 -
Center for Radiology Education Launches Nationwide Initiative to Provide Medical Imaging Scholarships at John Patrick University
17/03/2026 -
Polyrizon Signs an Agreement with Leading Global Preclinical CRO as Part of Clinical Development Program
17/03/2026 -
Axe Compute Appoints Two Technology and Telecom Luminaries to Board of Directors as Company Accelerates AI Infrastructure Strategy
17/03/2026 -
New InsiGHTS Trial of TransCon® hGH (Lonapegsomatropin) in Turner Syndrome Demonstrated Comparable Efficacy and Safety to Daily Somatropin at Week 52
17/03/2026 -
Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy
17/03/2026 -
ORAGENICS FILES ANNUAL REPORT ON FORM 10-K
17/03/2026 -
Polaryx Therapeutics Receives FDA Fast Track Designation for PLX‑200 for Late‑Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
17/03/2026 -
PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀’s New Drug Application
17/03/2026 -
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026
17/03/2026 -
Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors
17/03/2026 -
Longevity Health Holdings Closes Strategic Investment and Appoints Ram Ajjarapu as Chairman and CEO to Drive Acquisition-Focused Growth
17/03/2026 -
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody
17/03/2026 -
Sofwave Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Achieves Full-Year Profitability
17/03/2026 -
Grifols Shares Results From its Chronos Platform Identifying Early Molecular Changes Associated with Parkinson’s Disease
17/03/2026 -
Science 37 Launches Dedicated Pediatrics Department to Expand Access to Specialized Clinical Research for Children and Families
17/03/2026
Pages